Dexfenfluramine-induced prolactin release as an index of central synaptosomal 5-hydroxytryptamine during treatment with fluoxetine
- 1 June 1994
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 46 (5) , 441-444
- https://doi.org/10.1007/bf00191908
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- How Antidepressants Work: Cautionary Conclusions Based on Clinical and Laboratory Studies of the Longer‐Term Consequences of Antidepressant Drug TreatmentPublished by Wiley ,2007
- Reduction of food intake by manipulation of central serotonin. Current experimental results.1989
- Fluoxetine: A Serotonin‐specific, Second‐generation AntidepressantPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
- Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.British Journal of Clinical Pharmacology, 1983
- Prolactin-Lowering and -Releasing Drugs Mechanisms of Action and Therapeutic ApplicationsDrugs, 1983
- SEROTONIN RECEPTOR SENSITIVITY AFTER ACUTE AND CHRONIC TREATMENT WITH MIANSERIN1982
- FENFLURAMINE AND BRAIN SEROTONINAnnals of the New York Academy of Sciences, 1978
- The mechanism of action of fenfluramine.1975
- Amitriptyline in man: Decreased formation of central 5‐hydroxyindoleacetic acidClinical Pharmacology & Therapeutics, 1974
- 5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with ProbenecidNature, 1970